Thursday, November 17, 2011
Print Current Day:
|
|
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
NEW DEVELOPMENTS IN TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) AND ENDOVASCULAR TREATMENT OF OTHER CARDIAC AND ASCENDING AORTIC AND ARCH LESIONS (5-MINUTE TALKS)
Moderators:Roy K. Greenberg, MD / Bruce W. Lytle, MD
|
|
x | |
PROGRAM A (SESSIONS 11-13) LOCATION: GRAND BALLROOM, 3RD FLOOR | |
6:30 AM - 6:35 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
6:35 AM - 6:40 AM | Embolic Protection With The EMBRELLA Device To Cover The Origin Of The Innominate And Left Common Carotid During TAVI And TEVAR |
Presenter(s):Jeffrey P. Carpenter, MD | |
6:41 AM - 6:51 AM | Status Of TAVI: A Cardiologist’s View And Insights From The PARTNER A&B Trials |
Presenter(s):Martin B. Leon, MD | |
6:52 AM - 6:57 AM | Status Of Transcatheter Mitral Valve Repair: 2-Year Experience With The MitraClip For Mitral Insufficiency: The EVEREST II Trial |
Presenter(s):Ted Feldman, MD | |
6:58 AM - 7:03 AM | There Will Always Be A Need For Open Repair Of Ascending Aorta And Arch Lesions |
Presenter(s):Joseph S. Coselli, MD | |
7:04 AM - 7:09 AM | Transcardiac And Other Access Routes To The Ascending Aorta: Tips For Dealing With Difficult Access From Below |
Presenter(s):Tilo Koelbel, MD, PhD | |
7:10 AM - 7:15 AM | What Percentage Of Type A Aortic Dissections Could Be Treated Endovascularly |
Presenter(s):Stephan Haulon, MD | |
7:16 AM - 7:21 AM | Early Clinical Experience With Endovascular Treatment Of Type A Aortic Dissections By A Specially Designed Industry-Made Endograft |
Presenter(s):Matt M. Thompson, MD | |
7:22 AM - 7:27 AM | New Concepts In The Endovascular Treatment Of Type A Aortic Dissection |
Presenter(s):Nicola Mangialardi, MD | |
7:28 AM - 7:33 AM | Stent-Grafts In The Ascending Aorta: Do’s And Don’ts In View Of Open Repair Results And Findings |
Presenter(s):Burkhart Zipfel, MD | |
7:34 AM - 7:41 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
NEW DEVELOPMENTS IN MANAGEMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS (5-MINUTE TALKS)
Moderators:Larry H. Hollier, MD / Michel S. Makaroun, MD
|
|
x | |
PROGRAM A (SESSIONS 11-13) LOCATION: GRAND BALLROOM, 3RD FLOOR | |
7:41 AM - 7:46 AM | New Device For Branched Graft Reconstructions For Arch Aneurysms |
Presenter(s):Krassi Ivancev, MD, PhD | |
7:47 AM - 7:52 AM | Endovascular Treatment Of Aortic Arch Aneurysms: Early Clinical Experience With A Branched Arch Stent-Graft |
Presenter(s):Roy K. Greenberg, MD | |
7:53 AM - 7:58 AM | The Only Way To Chronic Treat Type B Aortic Dissections Is By Sealing The Primary Entry Tear And All Other Re-Entry Sites By Endovascular Methods |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
7:59 AM - 8:04 AM | Closing The Primary Entry Tear With An Endograft Is Only The First Step In Treating Chronic Type B Aortic Dissections Effectively |
Presenter(s):Pedro Puech, MD | |
8:05 AM - 8:10 AM | DEBATE: Chimney And Sandwich Techniques Are A Good Solution For Treating Arch Aneurysms |
Presenter(s):Armando C. Lobato, MD, PhD | |
8:11 AM - 8:16 AM | DEBATE: Respiratory And circulatory Motion Effects Make The Arch Unsuitable For Chimney And Sandwich Grafts For Revascularizing Arch Branches |
Presenter(s):Frank R. Arko, MD | |
8:17 AM - 8:22 AM | What Is The Incidence And Significance Of Aortic Remodeling, Complete And Partial After TEVAR For Acute Type B Aortic Dissection: Is Partial False Lumen Thrombosis Good Or Bad |
Presenter(s):Mark Conrad, MD | |
8:23 AM - 8:28 AM | Optimal Treatment For Chronic Type B Aortic Dissection: Do Newer Thoracic Endograft Systems Help |
Presenter(s):Giovanni Torsello, MD | |
8:29 AM - 8:34 AM | Early Experience And Use Of Single Branched Aortic Endograft To Treat Aortic Dissections |
Presenter(s):Zhong Gao Wang, MD | |
8:35 AM - 8:40 AM | Lessons Learned In 18 Years Of Treating Type B Aortic Dissections In Japan |
Presenter(s):Toru Kuratani, MD, PhD | |
8:41 AM - 8:47 AM | Panel Discussion |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
PROGRESS IN UNDERSTANDING AND MANAGEMENT OF AORTIC DISSECTIONS (5-MINUTE TALKS)
Moderators:Weiguo Fu, MD / Michael D. Dake, MD
|
|
x | |
PROGRAM A (SESSIONS 11-13) LOCATION: GRAND BALLROOM, 3RD FLOOR | |
8:48 AM - 8:53 AM | Techniques For Open Surgical Options For Complicated Type B Aortic Dissections Have Stood The Test Of Time: What Percentage Of Patients Will Require Open Surgery In The Future |
Presenter(s):Hazim J. Safi, MD | |
8:54 AM - 8:59 AM | A Novel Branch Stent Graft To Treat Aortic Arch Aneurysms And Dissections: Early And Mid-Term Results |
Presenter(s):Zaiping Jing, MD | |
9:00 AM - 9:05 AM | Endovascular Treatment Of Complicated Type B Aortic Dissections: Factors Determining How Much Aortic Coverage We Need And With What Sort Of Stent-Graft (Open Or Covered) |
Presenter(s):Matt M. Thompson, MD | |
9:06 AM - 9:11 AM | Quantitative Differences In False Lumen Evolution With And Without A Petticoat (Open Stent) Below A Standard Covered Stent For Type B Aortic Dissections |
Presenter(s):Germano Melissano, MD | |
9:12 AM - 9:17 AM | Disease-Specific Devices For Treating Type B Aortic Dissections: What Are The Results Of The STABLE Trial With A Proximal Covered And A Distal Bare Stent Showing Us |
Presenter(s):Joseph V. Lombardi, MD / Christoph A. Nienaber, MD, PhD | |
9:18 AM - 9:23 AM | What Is The Need For Open Repair Of Thoracic Aneurysms In The Endovascular Era: As Primary Procedures And After TEVAR Failures |
Presenter(s):Michael J. Jacobs, MD | |
9:24 AM - 9:29 AM | TEVAR For Acute Type B Dissections Is Not A Single Step Procedure: Permanent Surveillance And Reinterventions May Be Required |
Presenter(s):Götz M. Richter, MD, PhD | |
9:30 AM - 9:35 AM | The Natural History Of Type B Aortic Dissection: Which Patients Should We Treat: What We Know And What We Don’t Know |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
9:36 AM - 9:41 AM | Hybrid Procedures Still Have A Major Role For Complex And Difficult Aneurysms Of The Aortic Arch And Thoracic Aorta |
Presenter(s):Roberto Chiesa, MD | |
9:42 AM - 9:47 AM | What Are The Latest Results With TEVAR For Aneurysms Involving The Aortic Arch, Zones 0-3: Are The New Devices Helping |
Presenter(s):Dittmar Boeckler, MD | |
9:48 AM - 9:55 AM | Panel Discussion |
9:55 AM - 10:10 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
LOWER EXTREMITY HOT TOPICS 1 (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Kim J. Hodgson, MD
|
|
x | |
PROGRAM B (SESSIONS 14-16) LOCATION: TRIANON BALLROOM, 3RD FLOOR | |
6:35 AM - 6:40 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
6:40 AM - 6:45 AM | Optimizing POBA With Focal Force Balloons: What Are They And Do They Work With Heavily Calcified Arteries |
Presenter(s):Craig M. Walker, MD | |
6:46 AM - 6:51 AM | Tips And Tricks For Antegrade Puncture Of The CFA: How To Get The Wire Easily Into The SFA |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
6:52 AM - 6:57 AM | When And How To Use Embolic Protection Devices In The Lower Extremity |
Presenter(s):Peter A. Schneider, MD | |
6:58 AM - 7:03 AM | PTA (POBA) vs. Stenting For SFA/Popliteal Disease: Are Late Outcomes Equivalent |
Presenter(s):Kenneth Rosenfield, MD | |
7:04 AM - 7:09 AM | Endovascular vs. Open Surgical Treatments: A Common Sense Approach To The TASC System |
Presenter(s):Jos C. van den Berg, MD, PhD | |
7:10 AM - 7:15 AM | Role Of Bare Metal Stents For Below Knee Lesions Causing CLI: When Do They Help And When Not: Results Of The Belgian BTK Trial: What Is The Need For Reintervention At 1 Year |
Presenter(s):Frank E.G. Vermassen, MD, PhD | |
7:16 AM - 7:21 AM | Advantages And Limitations Of Drug Eluting Balloons (DEBs): Do They Improve On The Results Of PTA With Uncoated Balloons For The Treatment Of Primary Lesions And After Atherectomy |
Presenter(s):Gunnar Tepe, MD | |
7:22 AM - 7:27 AM | What Is The Effectiveness Of The Angioslide Embolic Debris Capture Device And When Should It Be Used |
Presenter(s):Thomas Zeller, MD | |
7:28 AM - 7:33 AM | Supera Veritas Stent: Why Is It A Better Solution For Extensive Femoropopliteal Disease |
Presenter(s):Peter C.J. Goverde, MD | |
7:34 AM - 7:40 AM | Panel Discussion |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Thursday
SESSION 15:
LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
|
|
x | |
7:40 AM - 7:45 AM | Tips And Tricks For Endovascular Treatment Of Chronically Occluded Prosthetic Bypasses Associated With CLI |
Presenter(s):Craig M. Walker, MD | |
7:46 AM - 7:51 AM | Endovascular Stenting Of CFA Lesions Is Possible And Can Be Associated With Good Midterm Outcomes |
Presenter(s):Nicolas A. Diehm, MD / Iris Baumgartner, MD | |
7:52 AM - 7:57 AM | DEBATE: Balloon PTA Is Usually Best In The Tibials: There Is Really A Need For Other Devices |
Presenter(s):Peter A. Schneider, MD | |
7:58 AM - 8:03 AM | DEBATE: Drug Eluting Stents (DESs) Used In Below Knee Arteries Improve Limb Salvage Outcomes Over POBA: Summary Of The Evidence |
Presenter(s):Thomas Zeller, MD | |
8:04 AM - 8:09 AM | Effectiveness Of Paclitaxil Coated DEBs For Treating In Stent Restenosis (The PACUBA Trial) |
Presenter(s):Johannes Lammer, MD | |
8:10 AM - 8:15 AM | 2-Year Results Of The Zilver PTX Trial: The Benefits Are Worthwhile |
Presenter(s):Michael D. Dake, MD | |
8:16 AM - 8:21 AM | Can Popliteal Stents Work: Tips, Tricks And Precautions |
Presenter(s):Gary M. Ansel, MD | |
8:22 AM - 8:27 AM | Top Ten Tips And New Technology For Performing Endovascular Treatments To The Foot: What Percentage Of Patients With CLI Will Need Open Surgery At Some Point In Their Ccourse: An Enthusiastic Inerventionalist's Perspective |
Presenter(s):Marco G. Manzi, MD | |
8:28 AM - 8:33 AM | Another View And Update On The Role Of DESs And DEBSs In Treating Below-Knee Disease: How Durable Are These Treatments |
Presenter(s):Andrej Schmidt, MD, PhD | |
8:34 AM - 8:39 AM | 2-Year Results With A Device To Remove The Atherosclerotic Core Of Long SFA Occlusions And Line It With A Distally Sented PTFE Graft Inserted Through The Groin |
Presenter(s):Patrice F. Bergeron, MD / Dieter Raithel, MD, PhD / Patrick Peeters, MD | |
8:40 AM - 8:46 AM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Thursday
SESSION 16:
LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
Moderators:George H. Meier III, MD / Max Amor, MD
|
|
x | |
8:46 AM - 8:51 AM | DEBATE: In Lower Extremity PTAs Intraluminal Is Better Than Subintimal |
Presenter(s):Marc Bosiers, MD | |
8:52 AM - 8:57 AM | DEBATE: Nonsentse, In Lower Extremity PTAs, Subintimal Is Better |
Presenter(s):George H. Meier III, MD | |
8:58 AM - 9:03 AM | Should PTAs Of The SFA Alwys Be Stented: Based On Prospective Follow-up Of 850 Patients |
Presenter(s):Robert Y. Rhee, MD | |
9:04 AM - 9:09 AM | Another View On Embolization During Lower Extremity Interventions: When Is Embolic Protection Needed And How Should It Be Done |
Presenter(s):Nicholas J. Morrissey, MD | |
9:10 AM - 9:15 AM | Tips And Tricks For Reentry Into The Lumen From The Subintimal Space |
Presenter(s):Peter A. Schneider, MD | |
9:16 AM - 9:21 AM | Another Single Center Experience Wth The Value Of DEBs For Femoropopliteal Lesions |
Presenter(s):Plinio Rossi, MD | |
9:22 AM - 9:27 AM | Does Debulking Before Using DEBs Help Wtih Primary Atherosclerotic Lesions; With In-Stent Restenosis: Ho Should It Be Done? |
Presenter(s):Andrej Schmidt, MD, PhD / Dierk Scheinert, MD | |
9:28 AM - 9:33 AM | Some Negative Aspects Of Tibial Angioplasty Based On U.S. Medicare Data In Patients With CLI: Complications Reshospitalizations And Amputations Are Frequent After The Procedures |
Presenter(s):Alan M. Graham, MD / Todd R. Vogel, MD | |
9:34 AM - 9:39 AM | Value Of Atherectomy Devices And Lasers For Lower Extremity Occlusive Lesions: Which Ones Make A Difference And When Should They Be Used |
Presenter(s):Thomas Zeller, MD | |
9:40 AM - 9:45 AM | Long-Term Results Of Ultrasound Enhanced Thrombolysis For Acute Arterial Occlusions: Results Of The Dutch Multicenter Study |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
9:46 AM - 9:51 AM | Panel Discussion |
9:46 AM - 9:51 AM | Panel Discussion |
9:51 AM - 10:10 AM | Break - Visit Exhibit and Pavilions (2nd and 3rd Floors) |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Thursday
SESSION 17:
NEW DEVELOPMENTS IN LOWER EXTREMITY SFA AND CRURAL ARTERY TREATMENT AND CLI TREATMENT (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / Barry T. Katzen, MD
|
|
x | |
PLENARY SESSION - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
10:10 AM - 10:15 AM | Flaws And Limitations In The TASC II Classification System: We Now Need Something Better: Will We Ever Get It |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
10:16 AM - 10:21 AM | What Are The Most Exciting New Developments In The Treatment Of Lower Extremity Ischemia: Will More Or Fewer LE Bypasses Be Required Than In The 25-30% Of CLI Patients Estimated Last Year |
Presenter(s):Joseph L. Mills, MD | |
10:22 AM - 10:27 AM | DEBATE: Endovascular First Is Not Appropriate For All CLI Patients: Evidence For A Selective Approach To Revascularization |
Presenter(s):Michael S. Conte, MD | |
10:28 AM - 10:33 AM | DEBATE: Endovascular First Is Best In All CLI Patients |
Presenter(s):Iris Baumgartner, MD | |
10:34 AM - 10:39 AM | Latest Information On Autologous Bone Marrow Cell: Administration For CLI: Does It Work: Is There Proof: Which Patients Should Have It |
Presenter(s):John (Jeb) W. Hallett, MD | |
10:40 AM - 10:45 AM | 12 Commandments For BTK Interventions For CLI |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
10:46 AM - 10:51 AM | Perfusion Imaging Is Mandatory To Demonstrate Efficacy Of PTA And Other Tibial Artery Interventions: Angiography Alone Can Be Misleading |
Presenter(s):Werner Lang, MD | |
10:52 AM - 10:57 AM | Results Of DESTINY RCT Comparing DESs (XCIENCE V) vs. Bare Metal Stents (BMS) In Below-Knee Lesions: DESs Give Better Patency Despite Increased Cost |
Presenter(s):Giovanni Torsello, MD / Marc Bosiers, MD | |
10:58 AM - 11:06 AM | Panel Discussion |
Moderator(s): Mark A. Adelman, MD / Plinio Rossi, MD | |
11:06 AM - 11:11 AM | Advances In Distal Puncture And Retrograde Crossing Of Occlusive Lesions: Puncture Of Tibial And Peroneal Arteries In Proximal Two-Thirds Of Leg And Use Of Collateral Branches |
Presenter(s):Andrej Schmidt, MD, PhD | |
11:12 AM - 11:17 AM | DEBATE: Current Status Of Bare Metal And Drug Eluting Stents In SFA, Popliteal And Crural Artery Lesions: DESs Are Best |
Presenter(s):Johannes Lammer, MD | |
11:18 AM - 11:23 AM | DEBATE: DESs In The SFA Is More Of The Same And A Waste Of Money |
Presenter(s):Patrick Peeters, MD | |
11:24 AM - 11:29 AM | Should Stents Be Used Routinely After SFA Subintimal Angioplasty |
Presenter(s):George H. Meier III, MD | |
11:30 AM - 11:35 AM | 1 ½-Year Results Of Drug Eluting Balloons In The Treatment Of SFA Lesions: The Italian Multicenter Trial |
Presenter(s):Giancarlo Biamino, MD, PhD | |
11:36 AM - 11:41 AM | Clinical And Cost Effectiveness Of Below-Knee DESs |
Presenter(s):Konstantinos Katsanos, MD, MSc, PhD, EBIR | |
11:42 AM - 11:47 AM | What To Watch Out For With DESs And DEBs: There May Be Real Disadvantages (Web-Based) |
Presenter(s):Renu Virmani, MD | |
11:48 AM - 11:53 AM | Below The Elbow PTA In Critical Hand Ischemia In Dialysis And Other Patients: A New Horizon |
Presenter(s):Roberto Ferraresi, MD | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 12:54 PM | Lunch Break – Americas Hall I, 3rd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Thursday
SESSION 18:
LUNCHEON PROGRAM: MANAGEMENT OF PROXIMAL VENOUS OBSTRUCTION. (PRE-REGISTRATION IS REQUIRED. PLEASE E-MAIL ADMIN@VEITHSYMPOSIUM.ORG TO PRE-REGISTER COMPLIMENTARY.)
Moderators:Kenneth Ouriel, MD, MBA, FACS, FACC / Jacob Cynamon, MD
|
|
x | |
SPECIAL LUNCHEON SESSION - LOCATION: CONFERENCE ROOM A, CONCOURSE LEVEL | |
12:00 PM - 12:05 PM | Opening Remarks |
Presenter(s):Kenneth Ouriel, MD, MBA, FACS, FACC | |
12:05 PM - 12:15 PM | Is There A Role For Thrombolysis And/Or Mechanical Thrombectomy In Acute Proximal Deep Venous Thrombosis |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
12:15 PM - 12:25 PM | The Use Of Venous Stenting For Subacute And Chronic Proximal Venous Obstruction |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
12:25 PM - 12:35 PM | Open Surgical Procedures Are Best For Obstruction Of The Iliofemoral Veins And Inferior Vena Cava |
Presenter(s):Peter Gloviczki, MD | |
12:35 PM - 12:55 PM | Discussion And Closing Remarks |
12:50 PM - 12:54 PM | Adjourn - Transition to Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor; AIMsymposium continues in the Trianon Ballroom, 3rd Floor. |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Thursday
SESSION 19:
NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
|
|
x | |
12:54 PM - 12:59 PM | How To Use 3D Imaging To Decrease Complications Of TAVI With The Edwards Sapien Balloon Expandable Aortic Valve |
Presenter(s):Erno Remsey-Semmelweis, MD, PhD | |
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
1:00 PM - 1:05 PM | DEBATE: New Evidence That Early TEVAR For Uncomplicated Acute Type B Aortic Dissection Is Superior To Medical Treatment And Delayed Selective TEVAR |
Presenter(s):Rodney A. White, MD | |
1:06 PM - 1:11 PM | DEBATE: TEVAR For Acute Type B Dissection May Not Be The Best Option In Most Patients |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
1:12 PM - 1:17 PM | How To Decrease Spinal Cord Ischemia (SCI) And Stroke After TEVAR: How To Perform CSF Drainage Optimally |
Presenter(s):Vincent Riambau, MD, PhD | |
1:18 PM - 1:23 PM | DEBATE: With Coverage Of Left Subclavian Orifice During TEVAR, Revascularization Is Mandatory: The SVS Guidelines Say So |
Presenter(s):Mark A. Farber, MD | |
1:24 PM - 1:29 PM | DEBATE: With Coverage Of Left Subclavian Orifice During TEVAR, Revascularization Is Not Mandatory And May Be harmful Based On New Multicenter Data |
Presenter(s):Thomas S. Maldonado, MD | |
1:30 PM - 1:35 PM | Sutureless Clampless Telescoping Method For Aortic And Arterial Anastomoses Using An Endograft Connector (Video) |
Presenter(s):Mario Lachat, MD | |
1:36 PM - 1:41 PM | DEBATE: Open Repair Should Be The Treatment Of Choice For Elective AAAs |
Presenter(s):Wilhelm Sandmann, MD | |
1:42 PM - 1:47 PM | DEBATE: EVAR Should Be The Treatment Of Choice For AAA In All Anatomically Suitable Patients Requiring Repair |
Presenter(s):Christopher K. Zarins, MD | |
1:48 PM - 1:53 PM | EVAR Is Better Than Open Repair Long-Term Despite EVAR I And Other Trials |
Presenter(s):Juan C. Parodi, MD | |
1:54 PM - 1:59 PM | Population Based Studies Show That EVAR Is Better Than Open Repair |
Presenter(s):Marc L. Schermerhorn, MD | |
2:00 PM - 2:05 PM | Twin Track Approach To Avoid Late AAA Sac Rupture After EVAR |
Presenter(s):Roger M. Greenhalgh, MD | |
2:06 PM - 2:11 PM | Panel Discussion |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Thursday
SESSION 20:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2011: WHERE IS IT AND WHERE IS IT GOING (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / Juan C. Parodi, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
2:11 PM - 2:16 PM | Tips And Tricks For Performing CAS Under Difficult Circumstances: Limitations Of Current Platforms And How Will They Be Improved |
Presenter(s):Bernhard Reimers, MD | |
2:17 PM - 2:22 PM | Tips And Tricks To Make CAS Safer: Why Do Most Strokes Occur After Embolic Protection Devices Are Out: How Can CAS Stroke Rates Best Be Decreased |
Presenter(s):Emmanuel M. Houdart, MD | |
2:23 PM - 2:28 PM | Beyond Technique And Embolic Protection How Can We Prevent Strokes With CAS: Where Do We Stand With Mesh Or Membrane Covered Stents |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
2:29 PM - 2:34 PM | Safety Of CAS WITHOUT Embolic Protection Devices: Why Do We Ignore The Evidence |
Presenter(s):Jos C. van den Berg, MD, PhD | |
2:35 PM - 2:40 PM | DEBATE: CAS Is The Treatment Of Choice For Most Symptomatic And Asymptomatic High-Grade Stenosis: A CAS Enthusiast Interprets CREST |
Presenter(s):William A. Gray, MD | |
2:41 PM - 2:46 PM | DEBATE: CEA Is Best For Most Symptomatic And Some Asymptomatic Carotid Stenosis Patients: A CEA Enthusiast Interprets CREST |
Presenter(s):Wesley S. Moore, MD | |
2:47 PM - 2:52 PM | DEBATE: Best Medical Treatment Is Best For Most Asymptomatic Cases: A Best Medical Treatment Enthusiast Interprets CREST And Other Data |
Presenter(s):Peter R.F. Bell, MD, FRCS, DSC, KBE | |
2:53 PM - 2:58 PM | The ICSS Trial: Why Were The Results Of ICSS So Different From CREST, Or Were They: Why Is ICSS Ignored In The U.S. |
Presenter(s):Jonathan D. Beard, MD | |
2:59 PM - 3:04 PM | It Is Not Possible To Justify CAS For Patients With Atherosclerotic Carotid Disease |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
3:05 PM - 3:11 PM | Panel Discussion |
Moderator(s): Peter R.F. Bell, MD, FRCS, DSC, KBE / Giorgio M. Biasi, MD | |
3:11 PM - 3:16 PM | DEBATE: Current Medical Intervention Alone Is Superior To CEA And CAS For Asymptomatic Carotid Arterial Disease |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
3:17 PM - 3:22 PM | DEBATE: We Can Now Select Asymptomatic Carotid Stenosis Patients Who Require CEA Or CAS With Confidence |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
3:23 PM - 3:28 PM | Do Statins And Medical Therapy Reduce Carotid Plaque Size, Embolic Potential And The Risk Of Stroke |
Presenter(s):Christos D. Liapis, MD | |
3:29 PM - 3:34 PM | Details Of CREST Data With Regard To Patients’ Symptomatic Status And Quality Of Life: Does A Minor MI Have More Serious Implications For Longevity Than A Minor Stroke – As Some Have Claimed |
Presenter(s):Thomas G. Brott, MD | |
3:35 PM - 3:40 PM | The AHA/ACC/ASA/SVS/Etc. Guidelines Are Misguided: CAS Is Not Yet An “Alternative” To CEA For Most Symptomatic Patients |
Presenter(s):Frank J. Veith, MD | |
3:41 PM - 3:46 PM | Carotid Stenosis Is A Rare Cause Of Stroke With Cardiac Surgery: Rarely Is CEA Or CAS Needed Before Or With Cardiac Surgery: When Is That |
Presenter(s):A. Ross Naylor, MD, FRCS | |
3:47 PM - 4:00 PM | Panel Discussion/Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
Thursday
SESSION 21:
NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS (5-MINUTE TALKS)
Moderators:Timur P. Sarac, MD / Daniel G. Clair, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
4:00 PM - 4:05 PM | Building A New Higher Neo-Aortic Bifurcation With Balloon Expandable Covered Stents (Atrium) Is A Better Way To Treat Severe Aortoiliac Occlusive Disease |
Presenter(s):Peter C.J. Goverde, MD | |
4:06 PM - 4:11 PM | Can 5 mm Diameter Stent-Grafts Be Used For SFA Occlusive Disease: Is Oversizing Stent-Grafts Good Or Bad: What Are The Modes Of Failure |
Presenter(s):Richard R. Saxon, MD, FSIR | |
4:12 PM - 4:17 PM | Are Stent-Grafts Better Than Bare Metal Stents In The SFA: The VIASTAR Results |
Presenter(s):Johannes Lammer, MD | |
4:18 PM - 4:23 PM | Are Long Stent-Grafts In The SFA Better Than Multiple Overlapping Shorter Devices: Current Status Of Heparin Bonded Stent-Grafts: Restenosis Does Not Correlate With Lesion Length |
Presenter(s):Thomas Zeller, MD | |
4:24 PM - 4:29 PM | What Is The Best Current Treatment For In Stent Restenosis |
Presenter(s):Marc Bosiers, MD | |
4:30 PM - 4:35 PM | Open Femoropopliteal PTFE Bypasses Are Superior To Endoluminal Stent-Graft Bypasses For 5-25 cm SFA Occlusions |
Presenter(s):Mauri J.A. Lepantalo, MD | |
4:36 PM - 4:41 PM | Lessons Learned In The Treatment Of Popliteal Aneurysms With Stent-Grafts: What Percentage Of Patients Can Be Treated: When Is Stent-Graft Treatment Contraindicated: What Are Recent Graft Improvements |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
4:42 PM - 4:47 PM | Long-Term Comparison Of Endo And Open Popliteal Aneurysm Repair: What Is The Current Role For Open Repair |
Presenter(s):Martin R. Back, MD / Dennis F. Bandyk, MD | |
4:48 PM - 4:53 PM | Panel Discussion |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Thursday
SESSION 22:
NEW OR UPDATED CONCEPTS IN VASCULAR DISEASE OR ITS TREATMENT: CONTROVERSY OVER THE INTERVENTIONAL TREATMENT OF CCSVI IN MULTIPLE SCLEROSIS (5-MINUTE TALKS)
Moderators:Lindsay Machan, MD / Frank J. Veith, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
4:53 PM - 4:58 PM | How To Identify Vulnerable Plaques And What To Do About Them |
Presenter(s):Gregg W. Stone, MD | |
4:59 PM - 5:04 PM | Modern Methods For Accurately Predicting Cardiac Risk In Vascular Surgery Patients |
Presenter(s):Jack L. Cronenwett, MD | |
THE CCSVI CONTROVERSY IN MULTIPLE SCLEROSIS | |
5:05 PM - 5:10 PM | Basics For Endovascular Treatment Of Multiple Sclerosis (MS): How Can Duplex Identify Large Vein Stenosis: An Enthusiast’s View |
Presenter(s):Paolo Zamboni, MD | |
5:11 PM - 5:16 PM | Does Interventional Treatment Help MS Patients: A Skeptic’s View |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
5:17 PM - 5:22 PM | Interventional Treatment Of CCSVI For MS: An Interventionalist’s Doubts And Hopes |
Presenter(s):Claudio Rabbia, MD, PhD | |
5:23 PM - 5:28 PM | Is Endovascular Treatment Going To Work For MS Patients: Status Of The PREMISE Randomized Controlled Trial: A Neuro-Interventionalist’s View |
Presenter(s):L. Nelson Hopkins, MD | |
5:29 PM - 5:34 PM | Extracranial Venous Obstruction In MS: Where Is It, What Can Be Done About It, How Do We Know It Works: Importance Of Pressure Gradients And Collaterals: An Interventionalist’s View |
Presenter(s):Michael D. Dake, MD | |
5:35 PM - 5:40 PM | Treatment Of Venous Obstruction Helps MS Patients: A Vascular Surgeon’s View |
Presenter(s):Manish Mehta, MD, MPH | |
5:41 PM - 5:46 PM | Interventional Treatment Of CCSVI For MS: Are Its Benefits Due To A Placebo Effect Or Are They Real: A Skeptical Neuro-Interventionalist's View (Web-Based) |
Presenter(s):Kieran Murphy, MD | |
5:47 PM - 5:52 PM | Submassive Pulmonary Emboli, An Unrecognized And Often Fatal Condition: Incidence, Diagnosis And Treatment With Ultrasonic Thrombolysis |
Presenter(s):Tod C. Engelhardt, MD | |
5:53 PM - 5:58 PM | Angiovac Endovascular Clot Removal System For Treatment Of Massive Pulmonary Emboli And Removal Of Large Clot Burdens |
Presenter(s):Christopher J. Kwolek, MD | |
5:59 PM - 6:09 PM | Panel Discussion |
END OF SESSION 22 | |
SESSION 23 SCHEDULE | |
Thursday
SESSION 23:
PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Hence J.M. Verhagen, MD, PhD / Palma M. Shaw, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
6:09 PM - 6:14 PM | Crossover Balloon Occlusion To Facilitate Percutaneous EVAR, TEVAR, TAVI And To Control Iliac Artery Ruptures And Femoral Artery Injuries |
Presenter(s):Mathew R. Williams, MD / Martin B. Leon, MD | |
6:15 PM - 6:20 PM | How Can Rhythm Disturbances Detected By An Implantable EKG Monitor (The REVEAL System) Help In Vascular Patient Management |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
6:21 PM - 6:26 PM | Tips And Tricks To Protect Interventionalists, Surgeons And Others From Radiation Exposure |
Presenter(s):Lindsay Machan, MD | |
6:27 PM - 6:32 PM | Antiplatelet Treatment Resistance In Vascular Disease Treatment: How Common Is It: How To Detect It: What Should Be Done About It |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
6:33 PM - 6:38 PM | DEBATE: Should We Test For Clopidogrel Resistance In Vascular Patients: No, It’s Not Worth The Time Or Money |
Presenter(s):Erich Minar, MD | |
6:39 PM - 6:44 PM | DEBATE: Yes! Look At The Coronary Data |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
6:45 PM - 6:50 PM | Panel Discussion |
6:50 PM - 6:50 PM | THURSDAY PROGRAM ENDS |
END OF SESSION 23 |